Landing, NJ—A bergamot extract blend, branded Bergacyn FF by DolCas Biotech, can help reduce liver fat and body weight, according to a new study, published in Frontiers in Endocrinology. The randomized, double-blind, placebo-controlled clinical trial studied 86 mildly hypercholesterolemic patients, age 35-70, with liver steatosis. They were given either 600mg/day...
San Diego, CA—Excessive consumption of fructose can result in non-alcoholic fatty liver disease (NAFLD). A new study says that, contrary to previous understanding, fructose only adversely affects the liver after it reaches the intestines, where the sugar disrupts the epithelial barrier protecting internal organs from bacterial toxins in the gut.
Landing, NJ—Results from a new clinical study published in The Journal of Traditional and Complementary Medicine show that Bergacyn, a botanical extract blend marketed by DolCas Biotech, has beneficial effects on reducing liver steatosis, inflammation and oxidative stress in type 2 diabetes, according to a press release. The 16-week, randomized,...
Dallas, TX—A natural compound found in cruciferous vegetables may play a role in controlling non-alcoholic fatty liver disease (NAFLD), according to a new study led by Texas A&M AgriLife Research scientists. The compound is called indole, and it is found in gut bacteria, as well as veggies including cabbage, kale,...
East Windsor, NJ—Sabinsa’s Curcumin C3 Complex was used in a new published study on Non-Alcoholic Fatty Liver Disease (NAFLD), the most common chronic liver condition for which no approved pharmaceutical treatments exist, according to a press release. NAFLD is a spectrum of disorders ranging from steatosis to cirrhosis of the...
